Efficacy of Protein Supplementation in Preventing Muscle Mass Loss During the Weight Loss Process.

• Participants of both sexes aged between 25 and 60 years.
• Ability to understand and accept participation in the study, indicated by signing the Informed Consent Form approved by the Ethics Committee.
• Good health status, determined by the absence of significant findings in medical history, physical examination, laboratory tests, and vital sign measurements.
• Agree to comply with the planned study procedures and attend visits.
• Participants with the capacity and motivation to perform resistance training 3 to 5 times per week (150 to 200 minutes/week); - Participants with a body mass index (BMI) ≥ 27.0 kg/m².

Exclusion Criteria:

• Known allergy to components of the investigational product or placebo;
• History of chronic use in the last 3 months or current use of medications or substances that affect the muscular system;
• Current history of type 1 or 2 diabetes mellitus, gastrointestinal, cardiovascular, renal, or hepatic diseases, or malignant neoplasm, considered clinically significant at the physician's discretion.
• Abuse of illicit drugs or alcohol, as clinically assessed by the investigator during screening.
• Having participated in a clinical study in the last 12 months at the investigator's discretion.
• Having any condition that prevents participation in the study at the investigator's discretion.